| BCBS Florida Coverage Guidelines | New-To-Market Program for Medical Benefit (09-J4000-30) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Nitisinone (Orfadin®, Nityr™, Harliku™) (09-J1000-27) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Non-Covered Services (09-A0000-00) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Ozanimod (Zeposia®) Capsules (09-J3000-70) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tibial Nerve Stimulation (02-64000-01) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Electrical Nerve Stimulation (02-61000-03) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Preventive Services (01-99385-03) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Risankizumab-rzaa (Skyrizi®) Injection and (09-J3000-45) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Ritlecitinib (Litfulo) Capsule (09-J4000-57) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Sapropterin (Kuvan®, Javygtor™) Tablets, (09-J0000-74) | 2026-01-01 |